Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis

Journal of Hepatology

Volumn 52, Issue 2, 2010, Pages 199-205

  Testro, Adam G ^a   Gow, Paul J ^a   Angus, Peter W ^a   Wongseelashote, Sarah ^a   Skinner, Narelle ^b   Markovska, Vesna ^b   Visvanathan, Kumar ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Antibiotics; Cirrhosis; Cytokine; Endotoxin; Innate immunity; Spontaneous bacterial peritonitis; Toll like receptors

Indexed keywords

COTRIMOXAZOLE; NORFLOXACIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DECOMPENSATED LIVER CIRRHOSIS; DOWN REGULATION; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NORFLOXACIN; PERITONITIS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75349083870     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.11.006     Document Type: Article

References (48)

1. Fernandez J., Navasa M., Gomez J., Colmenero J., Vila J., Arroyo V., et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35 (2002) 140-148
2. Ramachandran A., and Balasubramanian K.A. Intestinal dysfunction in liver cirrhosis: its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol 16 (2001) 607-612
3. Tito L., Rimola A., Gines P., Llach J., Arroyo V., and Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 8 (1988) 27-31
4. Wong F., Bernardi M., Balk R., Christman B., Moreau R., Garcia-Tsao G., et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54 (2005) 718-725
5. Fernandez J., Navasa M., Planas R., Montoliu S., Monfort D., Soriano G., et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133 (2007) 818-824
6. Rolachon A., Cordier L., Bacq Y., Nousbaum J.B., Franza A., Paris J.C., et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 22 (1995) 1171-1174
7. Singh N., Gayowski T., Yu V.L., and Wagener M.M. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 122 (1995) 595-598
8. Rasaratnam B., Kaye D., Jennings G., Dudley F., and Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 139 (2003) 186-193
9. Riordan S.M., Skinner N., Nagree A., McCallum H., McIver C.J., Kurtovic J., et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 37 (2003) 1154-1164
10. Medzhitov R., and Janeway Jr. C. Innate immunity. N Engl J Med 343 (2000) 338-344
11. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2 (2001) 675-680
12. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., and Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163 (1999) 1-5
13. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
14. Manigold T., Bocker U., Hanck C., Gundt J., Traber P., Antoni C., et al. Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 15 (2003) 275-282
15. Mandrekar P., Catalano D., and Szabo G. Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes. Int Immunol 11 (1999) 1781-1790
16. Mandrekar P., Catalano D., and Szabo G. Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. Alcohol Clin Exp Res 21 (1997) 988-994
17. Mandrekar P., Catalano D., White B., and Szabo G. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. Alcohol Clin Exp Res 30 (2006) 135-139
18. Mandrekar P., Jeliazkova V., Catalano D., and Szabo G. Acute alcohol exposure exerts anti-inflammatory effects by inhibiting IkappaB kinase activity and p65 phosphorylation in human monocytes. J Immunol 178 (2007) 7686-7693
19. Enomoto N., Ikejima K., Bradford B., Rivera C., Kono H., Brenner D.A., et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 115 (1998) 443-451
20. Alexander J.F., Lischner M.W., and Galambos J.T. Natural history of alcoholic hepatitis. II. The long-term prognosis. Am J Gastroenterol 56 (1971) 515-525
21. Powell Jr. W.J., and Klatskin G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 44 (1968) 406-420
22. Reynolds T.B., Geller H.M., Kuzma O.T., and Redeker A.G. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med 263 (1960) 734-739
23. Runyon B.A. Historical aspects of treatment of patients with cirrhosis and ascites. Semin Liver Dis 17 (1997) 163-173
24. Heagy W., Hansen C., Nieman K., and West M.A. Evidence for a CD14- and serum-independent pathway in the induction of endotoxin-tolerance in human monocytes and THP-1 monocytic cells. Shock 19 (2003) 321-327
25. Koons A., Crandall M., An G.C., Shapiro M.B., Kramer S., and West M.A. Even ephemeral endotoxin exposure establishes endotoxin tolerance. J Trauma 64 (2008) 938-942
26. West M.A., and Koons A. Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J Trauma 65 (2008) 893-898 [discussion 898-900]
27. Cavaillon J.M., and Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10 (2006) 233
28. Nanji A.A., Khettry U., and Sadrzadeh S.M. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205 (1994) 243-247
29. Tsukamoto H., Towner S.J., Ciofalo L.M., and French S.W. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 6 (1986) 814-822
30. Adachi Y., Moore L.E., Bradford B.U., Gao W., and Thurman R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108 (1995) 218-224
31. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164 (2000) 3476-3479
32. Lin C.Y., Tsai I.F., Ho Y.P., Huang C.T., Lin Y.C., Lin C.J., et al. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol 46 (2007) 816-826
33. von Baehr V., Docke W.D., Plauth M., Liebenthal C., Kupferling S., Lochs H., et al. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 47 (2000) 281-287
34. Heller J., Sogni P., Barriere E., Tazi K.A., Chauvelot-Moachon L., Guimont M.C., et al. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 33 (2000) 376-381
35. Ramirez M.J., Ibanez A., Navasa M., Casals E., Morales-Ruiz M., Jimenez W., et al. High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites. J Hepatol 40 (2004) 424-430
36. Runyon B.A., Squier S., and Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 21 (1994) 792-796
37. Llovet J.M., Bartoli R., Planas R., Cabre E., Jimenez M., Urban A., et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 35 (1994) 1648-1652
38. Llovet J.M., Bartoli R., Planas R., Vinado B., Perez J., Cabre E., et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 23 (1996) 781-787
39. Garcia-Tsao G., Lee F.Y., Barden G.E., Cartun R., and West A.B. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108 (1995) 1835-1841
40. Rimola A., Soto R., Bory F., Arroyo V., Piera C., and Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4 (1984) 53-58
41. Bolognesi M., Merkel C., Bianco S., Angeli P., Sacerdoti D., Amodio P., et al. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. Hepatology 19 (1994) 628-634
42. Guarner C., and Runyon B.A. Macrophage function in cirrhosis and the risk of bacterial infection. Hepatology 22 (1995) 367-369
43. Gomez F., Ruiz P., and Schreiber A.D. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 331 (1994) 1122-1128
44. Homann C., Varming K., Hogasen K., Mollnes T.E., Graudal N., Thomsen A.C., et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 40 (1997) 544-549
45. Fiuza C., Salcedo M., Clemente G., and Tellado J.M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 182 (2000) 526-533
46. Runyon B.A., Morrissey R.L., Hoefs J.C., and Wyle F.A. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 5 (1985) 634-637
47. Nakamura T., Morizane T., Watanabe T., Tsuchimoto K., Inagaki Y., Kumagai N., et al. Decreased natural killer activity in patients with liver cirrhosis. Int J Cancer 32 (1983) 573-575
48. Garcia-Gonzalez M., Boixeda D., Herrero D., and Burgaleta C. Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis. Gastroenterology 105 (1993) 527-531